AAAAAA
Results: 276-300/1318
Authors:
KENNEDY I
SEWELL H
Citation: I. Kennedy et H. Sewell, XENOTRANSPLANTATION MORATORIUM, Nature biotechnology, 16(2), 1998, pp. 120-120
Authors:
DAVIDSON S
Citation: S. Davidson, NEW EUROPEAN CLINICAL-TRIAL REGULATIONS ARE UNACCEPTABLE TO INDUSTRY, Nature biotechnology, 16(2), 1998, pp. 127-127
Authors:
FOX JL
Citation: Jl. Fox, USDA ASKS CAN ORGANIC FOODS BE RECOMBINANT, Nature biotechnology, 16(2), 1998, pp. 128-128
Authors:
MARSHALL A
Citation: A. Marshall, HGS LAUNCHES FIRST GENOMICS PRODUCT IN CLINIC, Nature biotechnology, 16(2), 1998, pp. 129-129
Authors:
BROWER V
Citation: V. Brower, THROMBOLYTICS STILL AHEAD, DESPITE STUDY THAT FAVORS ANGIOPLASTY, Nature biotechnology, 16(2), 1998, pp. 130-131
Authors:
PERRENBOOM E
Citation: E. Perrenboom, GERMAN GREENS ATTENUATE THEIR GENETIC-RESISTANCE, Nature biotechnology, 16(2), 1998, pp. 130-130
Authors:
FOX JL
Citation: Jl. Fox, EPA BAN ON BROMOXYNIL UNDERCUTS CALGENES TRANSGENIC COTTON, Nature biotechnology, 16(2), 1998, pp. 132-133
Authors:
CHAHINE K
Citation: K. Chahine, US COURTS DISAGREE ON GENERIC DRUG EXCLUSIVITY, Nature biotechnology, 16(2), 1998, pp. 132-132
Authors:
FRANCISCO M
Citation: M. Francisco, REGIONAL STOCK EXCHANGES TRADE BIOTECHNOLOGY STOCK-OPTIONS, Nature biotechnology, 16(2), 1998, pp. 133-133
Authors:
TICE T
STAAS J
Citation: T. Tice et J. Staas, GETTING TO THE HEART OF GROWTH-FACTOR DELIVERY, Nature biotechnology, 16(2), 1998, pp. 134-134
Authors:
POTTS RO
CHIZMADZHEV YA
Citation: Ro. Potts et Ya. Chizmadzhev, OPENING DOORS FOR EXOGENOUS AGENTS, Nature biotechnology, 16(2), 1998, pp. 135-135
Authors:
EDELMAN ER
LOVICH M
Citation: Er. Edelman et M. Lovich, DRUG-DELIVERY MODELS TRANSPORTED TO A NEW LEVEL, Nature biotechnology, 16(2), 1998, pp. 136-137
Authors:
BIALY H
Citation: H. Bialy, ANEUPLOIDY AND CANCER - VINTAGE WINE IN A NEW BOTTLE, Nature biotechnology, 16(2), 1998, pp. 137-138
Authors:
HIGGINS DE
PORTNOY DA
Citation: De. Higgins et Da. Portnoy, BACTERIAL DELIVERY OF DNA EVOLVES, Nature biotechnology, 16(2), 1998, pp. 138-139
Authors:
GATZ C
Citation: C. Gatz, AN INTOXICATING SWITCH FOR PLANT TRANSGENE EXPRESSION, Nature biotechnology, 16(2), 1998, pp. 140-140
Authors:
PATTON J
Citation: J. Patton, BREATHING LIFE INTO PROTEIN DRUGS - INHALATION OF THERAPEUTIC MACROMOLECULES IS A FEASIBLE, NATURAL, MORE PEOPLE-FRIENDLY, DELIVERY SYSTEM, Nature biotechnology, 16(2), 1998, pp. 141-143
Authors:
WITHAM C
Citation: C. Witham, NEW LIFE FOR OLD DRUGS, Nature biotechnology, 16(2), 1998, pp. 142-142
Authors:
MCGAUGHEY WH
GOULD F
GELERNTER W
Citation: Wh. Mcgaughey et al., BT RESISTANCE MANAGEMENT, Nature biotechnology, 16(2), 1998, pp. 144-146
Authors:
HODGSON J
Citation: J. Hodgson, MAKING MAGNETS TO GLOBAL BIOTECHNOLOGY PEOPLE, Nature biotechnology, 16(2), 1998, pp. 147-148
Authors:
LAHTEENMAKI R
HODGSON J
Citation: R. Lahteenmaki et J. Hodgson, INVESTMENT INDICATORS SHOW US IS STILL AHEAD, Nature biotechnology, 16(2), 1998, pp. 149-150
Authors:
SAEGUSA A
Citation: A. Saegusa, BIOTECHNOLOGY UNSCATHED IN KOREAN FINANCE CRISIS, Nature biotechnology, 16(2), 1998, pp. 151-151
Authors:
PUTNEY SD
BURKE PA
Citation: Sd. Putney et Pa. Burke, IMPROVING PROTEIN THERAPEUTICS WITH SUSTAINED-RELEASE FORMULATIONS, Nature biotechnology, 16(2), 1998, pp. 153-157
Authors:
ARRAS M
MOLLNAU H
STRASSER R
WENZ R
ITO WD
SCHAPER J
SCHAPER W
Citation: M. Arras et al., THE DELIVERY OF ANGIOGENIC FACTORS TO THE HEART BY MICROSPHERE THERAPY, Nature biotechnology, 16(2), 1998, pp. 159-162
Authors:
KUO PY
SHERWOOD JK
SALTZMAN WM
Citation: Py. Kuo et al., TOPICAL ANTIBODY DELIVERY SYSTEMS PRODUCE SUSTAINED LEVELS IN MUCOSALTISSUE AND BLOOD, Nature biotechnology, 16(2), 1998, pp. 163-167
Authors:
ROLS MP
DELTEIL C
GOLZIO M
DUMOND P
CROS S
TEISSIE J
Citation: Mp. Rols et al., IN-VIVO ELECTRICALLY MEDIATED PROTEIN AND GENE-TRANSFER IN MURINE MELANOMA, Nature biotechnology, 16(2), 1998, pp. 168-171